Literature DB >> 16525742

[Gold. Effective therapy for mucosal lesions of pemphigus vulgaris].

D Lange1, F Meiss, E Fiedler, K Treiber, W C Marsch, M Fischer.   

Abstract

High-dose steroids in combination with other immunosuppressant substances, usually azathioprine, are the therapy of choice in pemphigus vulgaris. Complete remission can be difficult to achieve, with mucosal lesions often recalcitrant. We describe two patients in whom gold in the form of sodium aurothiomalate was effective in resolving mucosal lesions. Initially both patients were treated with high-dose corticosteroids, one in combination with mycophenolate mofetil. Their oral lesions proved to be stubborn but responded well to intramuscular gold, which also showed a steroid-sparing effect, so that the dosage of corticosteroids could be reduced to a minimum. Sodium aurothiomalate was continued until both patients were in remission without any side effects.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 16525742     DOI: 10.1007/s00105-006-1102-2

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  28 in total

1.  TNFalpha and IL-6 are mediators in the blistering process of pemphigus.

Authors:  E López-Robles; E Avalos-Díaz; E Vega-Memije; T Hojyo-Tomoka; R Villalobos; S Fraire; L Domíguez-Soto; R Herrera-Esparza
Journal:  Int J Dermatol       Date:  2001-03       Impact factor: 2.736

2.  Pemphigus therapy with oral prednisolone regimens. A 5-year study.

Authors:  K V Ratnam; K L Phay; C K Tan
Journal:  Int J Dermatol       Date:  1990-06       Impact factor: 2.736

3.  Effects of gold on cytokine production in vitro; increase of monocyte dependent interleukin 10 production and decrease of interferon-gamma levels.

Authors:  Jon Lampa; Lars Klareskog; Johan Rönnelid
Journal:  J Rheumatol       Date:  2002-01       Impact factor: 4.666

4.  Treatment of oral pemphigus vulgaris.

Authors:  F Chrysomallis; D Ioannides; A Teknetzis; D Panagiotidou; A Minas
Journal:  Int J Dermatol       Date:  1994-11       Impact factor: 2.736

5.  Therapy of refractory pemphigus vulgaris with monoclonal anti-CD20 antibody (rituximab).

Authors:  Lynne H Morrison
Journal:  J Am Acad Dermatol       Date:  2004-11       Impact factor: 11.527

6.  Childhood pemphigus vulgaris treated with dapsone: a case report.

Authors:  B Bjarnason; C Skoglund; E Flosadóttir
Journal:  Pediatr Dermatol       Date:  1998 Sep-Oct       Impact factor: 1.588

7.  Dexamethasone-cyclophosphamide pulse therapy for pemphigus.

Authors:  J S Pasricha; B K Khaitan; R S Raman; M Chandra
Journal:  Int J Dermatol       Date:  1995-12       Impact factor: 2.736

Review 8.  Consensus statement on the use of intravenous immunoglobulin therapy in the treatment of autoimmune mucocutaneous blistering diseases.

Authors:  A Razzaque Ahmed; Mark V Dahl
Journal:  Arch Dermatol       Date:  2003-08

9.  [Gold therapy in pemphigus].

Authors:  H Barriere; C Pasquiou; J L Forest
Journal:  Ann Dermatol Venereol       Date:  1977-11       Impact factor: 0.777

10.  Lichen planus and acne provoked by gold.

Authors:  A Hjortshoj
Journal:  Acta Derm Venereol       Date:  1977       Impact factor: 4.437

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.